What are you looking for?
This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information
Choose your country
Visit us at ESCMID Global in Vienna, Austria, from 11 to 15 April 2025, booth E35 in the Exhibition & Congress Center.
moreEUROIMMUN and IDS combine quality and progress in a unique way, offering comprehensive panels of accurate and reliable chemiluminescence assays – backed up by extensive scientific studies – and maximum walk-away automation.
WebsiteDetection of anti-measles virus antibodies now also possible using dried blood spots (DBS) - minimally invasive sampling and high sample stability.
moreBenefit from our years of experience in state-of-the-art in vitro diagnostics during our theoretical and practical trainings.
moreIn the therapy of Alzheimer’s disease with new active substances (e.g. lecanemab, donanemab), patients with two copies of the apolipoprotein E (APOE) allele ε4 have an increased risk of potentially life-threatening side effects. APOE genotyping with the EURORealTime APOE prior to therapy provides clarity.
moreWe develop and globally distribute complete diagnostic solutions that are tailored to your local needs.
WebsiteUnlock new potential – 23 new assays for the UNIQO 160
Test systems backed up by extensive scientific studies [...]
EUROLabPolaris Support Platform – Personalised support for your IFA evaluation
Line blot for myositis shows high agreement with biopsy
Role of Epstein-Barr virus in multiple sclerosis
Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay